The valuation part of the presentation seemed surprising to the low side... A comparative antibiotic - not an anti infective mind you, but still - went through phase 3 and struck a deal worth $150m up front bullet with various bullet payments of $25m for sales targets reached. If that was all we could expect, it would be hard to justify a valuation much above the $25m usd floated in the case study... I was always expecting a larger chunk to be retained by recce.... I thought that was weird and underwhelming and confusing... Noting that recce has production capability, how should one think about the 'tax' paid in distribution and sales networks and a reasonable way to think about valuation?
- Forums
- ASX - By Stock
- Ann: Anti-Infective Portfolio Update and Webinar details
The valuation part of the presentation seemed surprising to the...
Featured News
Add RCE (ASX) to my watchlist
(20min delay)
|
|||||
Last
46.5¢ |
Change
-0.005(1.06%) |
Mkt cap ! $103.1M |
Open | High | Low | Value | Volume |
47.0¢ | 47.0¢ | 46.0¢ | $35.74K | 76.24K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 45328 | 46.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
47.0¢ | 28489 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 45328 | 0.465 |
2 | 84391 | 0.460 |
6 | 96229 | 0.455 |
11 | 127229 | 0.450 |
4 | 114597 | 0.440 |
Price($) | Vol. | No. |
---|---|---|
0.470 | 28489 | 2 |
0.475 | 10000 | 1 |
0.480 | 16600 | 1 |
0.485 | 2063 | 1 |
0.490 | 12000 | 1 |
Last trade - 15.55pm 02/08/2024 (20 minute delay) ? |
Featured News
GML
Gateway Mining sells WA Eastern Montague gold project to Brightstar for $14M – half of that in shares
KAI
Pilbara Minerals buys land off Kairos part of its York gold project for $20M – and a 2% royalty on any PLS gold sales
RCE (ASX) Chart |